Moomoo AI 已提取核心訊息
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 3,162 shares of common stock on January 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $1.4294 each, resulting in a total sale value of approximately $4,519.76. Following the sale, Obenshain's direct holdings in the company amount to 287,972 shares of common stock.
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 3,162 shares of common stock on January 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $1.4294 each, resulting in a total sale value of approximately $4,519.76. Following the sale, Obenshain's direct holdings in the company amount to 287,972 shares of common stock.
藍鳥生物公司總裁兼首席執行官安德魯·奧本沙因於2024年1月5日完成了3,162股普通股的出售。該交易在公開市場上進行，股票以每股1.4294美元的價格出售，總銷售價值約爲4519.76美元。出售後，Obenshain在該公司的直接持有量爲287,972股普通股。
藍鳥生物公司總裁兼首席執行官安德魯·奧本沙因於2024年1月5日完成了3,162股普通股的出售。該交易在公開市場上進行，股票以每股1.4294美元的價格出售，總銷售價值約爲4519.76美元。出售後，Obenshain在該公司的直接持有量爲287,972股普通股。
有用
沒用